GASTROGRAFIN LIQ 10 %
DIATRIZOATE SODIUM : 10 % DIATRIZOATE MEGLUMINE : 66 % · DIN 01995669 · SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is GASTROGRAFIN LIQ?
GASTROGRAFIN LIQ 10 % contains DIATRIZOATE SODIUM : 10 % DIATRIZOATE MEGLUMINE : 66 %. It is listed in the Health Canada Drug Product Database under DIN 01995669, held by SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC., supplied as LIQUID for ORAL ; REFER (SEE DOSAGE FORM) administration. Health Canada currently lists it as cancelled post market, status dated 14-Aug-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01995669 |
|---|---|
| Brand name | GASTROGRAFIN LIQ |
| Generic / active ingredient | DIATRIZOATE SODIUM : 10 % DIATRIZOATE MEGLUMINE : 66 % |
| Manufacturer | SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. |
| Strength | 10 % |
| Dosage form | LIQUID |
| Route of administration | ORAL ; REFER (SEE DOSAGE FORM) |
| Schedule | Ethical |
| ATC code | V08AA01 DIATRIZOIC ACID |
| AHFS class | 36:68.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 14-Aug-1997 |
| Original market date | 1958-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code V08AA01 DIATRIZOIC ACID. 1 of 30 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| GASTROGRAFIN | 10 % | SOLUTION | BRACCO IMAGING CANADA | MARKETED | DIN 02228564 |
| HYPAQUE ORAL LIQUID - 50G/120ML | 50 G / 120 ML | LIQUID | NYCOMED IMAGING A.S. | CANCELLED POST MARKET | DIN 02180626 |
| HYPAQUE ORAL LIQUID 50GM/120ML | 50 G / 120 ML | LIQUID | SANOFI CANADA, INC. | CANCELLED POST MARKET | DIN 02026902 |
| HYPAQUE ORAL POWDER | 997.4 MG | POWDER | GE HEALTHCARE CANADA INC | CANCELLED POST MARKET | DIN 02180685 |
| HYPAQUE ORAL POWDER 0.9974G/G | 997.4 MG | POWDER | SANOFI CANADA, INC. | CANCELLED POST MARKET | DIN 02026988 |
| HYPAQUE PWR 100% | 100 % | POWDER | STERLING WINTHROP INC. | CANCELLED POST MARKET | DIN 01905007 |
| HYPAQUE SODIUM 50% - LIQ IV | 50 % | LIQUID | NYCOMED IMAGING A.S. | CANCELLED POST MARKET | DIN 02180650 |
| HYPAQUE SODIUM 50% LIQ | 50 % | LIQUID | STERLING WINTHROP INC. | CANCELLED POST MARKET | DIN 01902768 |
| HYPAQUE SODIUM LIQ 50% | 50 % | LIQUID | SANOFI CANADA, INC. | CANCELLED POST MARKET | DIN 02017784 |
| HYPAQUE-M 18% | 18 % | SOLUTION | AMERSHAM HEALTH INC | CANCELLED POST MARKET | DIN 02180634 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.